Vertex Pharmaceuticals
(NASDAQ:VRTX)
$394.595
1.115[0.28%]
Last update: 12:30PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Vertex Pharmaceuticals Stock (NASDAQ:VRTX), Quotes and News Summary

Vertex Pharmaceuticals Stock (NASDAQ: VRTX) stock price, news, charts, stock research, profile.

Open$394.720
Close-
Volume / Avg.458.252K / 1.236M
Day Range392.995 - 396.980
52 Wk Range316.430 - 448.400
Market Cap$101.987B
P/E Ratio28.328
Dividend Yield-
ExchangeNASDAQ
RSI
35
Short Interest
1.54%
Days to Cover4.54

Recent News

Tesla To $123? Here Are 10 Top Analyst Forecasts For Thursday
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Avi Kapoor
Vertex's Alpine Acquisition: Unpacking Analyst Predictions on Povetacicept's Potential Impact
Vertex Pharmaceuticals to acquire Alpine Immune Sciences for $4.9 billion, expanding into nephrology with promising APOL1-mediated kidney disease treatments. Analysts foresee significant revenue growth potential, with Alpine's lead molecule poised to add over $5 billion in sales.
Vandana Singh
Stocks Bounce Back With Tech, Gold Gaining After Modest Producer Inflation Data: What's Driving Markets Thursday?
Investors can breathe a sigh of relief on Thursday as last month’s Producer Price Index (PPI) inflation turned out slightly lower than expected, albeit with some caveats across different measures within the basket.
Piero Cingari
40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
4
1
Nov 23
4
Dec 23
5
1
Jan
8
1
Feb
5
1
Apr
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Vertex Pharmaceuticals, Inc.
Sector
Health Care
Industry
Biotechnology
Vertex Pharmaceuticals is a global biotechnology company that discovers and develops small-molecule ...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
VRTX
LEGN

FAQ

Q

How do I buy Vertex Pharmaceuticals (VRTX) stock?

A

You can purchase shares of Vertex Pharmaceuticals (NASDAQ: VRTX) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Vertex Pharmaceuticals's (VRTX) competitors?

A

Other companies in Vertex Pharmaceuticals’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).

Q

What is the target price for Vertex Pharmaceuticals (VRTX) stock?

A

The latest price target for Vertex Pharmaceuticals (NASDAQ: VRTX) was reported by Guggenheim on Thursday, April 18, 2024. The analyst firm set a price target for 450.00 expecting VRTX to rise to within 12 months (a possible 14.04% upside). 84 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Vertex Pharmaceuticals (VRTX)?

A

The stock price for Vertex Pharmaceuticals (NASDAQ: VRTX) is $394.595 last updated Today at April 19, 2024 at 12:30 PM EDT.

Q

Does Vertex Pharmaceuticals (VRTX) pay a dividend?

A

There are no upcoming dividends for Vertex Pharmaceuticals.

Q

When is Vertex Pharmaceuticals (NASDAQ:VRTX) reporting earnings?

A

Vertex Pharmaceuticals’s Q1 earnings are confirmed for Monday, May 6, 2024.

Q

Is Vertex Pharmaceuticals (VRTX) going to split?

A

There is no upcoming split for Vertex Pharmaceuticals.

Q

What sector and industry does Vertex Pharmaceuticals (VRTX) operate in?

A

Vertex Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch